Information from pharmaceutical companies and the quality, quantity, and cost of physicians' prescribing: a systematic review
Background Pharmaceutical companies spent $57.5 billion on pharmaceutical promotion in the United States in 2004. The industry claims that promotion provides scientific and educational information to physicians. While some evidence indicates that promotion may adversely influence prescribing, physi...
保存先:
主要な著者: | Spurling, Geoffrey K., Mansfield, Peter R., Montgomery, Brett D., Lexchin, Joel, Doust, Jenny, Othman, Noordin, Vitry, Agnes I. |
---|---|
フォーマット: | 論文 |
言語: | English |
出版事項: |
Public Library of Science
2010
|
主題: | |
オンライン・アクセス: | http://irep.iium.edu.my/346/1/journal.pmed.1000352.pdf http://irep.iium.edu.my/346/ http://dx.doi.org/10.1371/journal.pmed.1000352 |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|
類似資料
-
Quality of pharmaceutical advertisements in medical journals: a systematic review
著者:: Othman, Noordin, 等
出版事項: (2009) -
Pharmaceutical promotion : the theoretical framework of regulation.
著者:: Othman, Noordin, 等
出版事項: (2011) -
The challenge of pharmaceutical promotion regulation in Malaysia.
著者:: Othman, Noordin, 等
出版事項: (2011) -
Prescribing of Strong Opioid Analgesics by UK Primary Care Physicians from 2000 to 2010
著者:: Zin, Che Suraya, 等
出版事項: (2012) -
Prescribing of strong opioid analgesics by UK primary care physicians from 2000 to 2010
著者:: Zin, Che Suraya, 等
出版事項: (2012)